Posaconazole
Noxafil (posaconazole) is a small molecule pharmaceutical. Posaconazole was first approved as Noxafil on 2005-10-25. It is used to treat mycoses and oral candidiasis in the USA. It has been approved in Europe to treat aspergillosis, candidiasis, coccidioidomycosis, and mycoses. Noxafil's patents are valid until 2033-02-27 (FDA).
| Trade Name | Noxafil |
|---|---|
| Common Name | Posaconazole |
| Indication | aspergillosis, candidiasis, coccidioidomycosis, mycoses, oral candidiasis |
| Drug Class | Systemic antifungals (miconazole type) |
